Direct Flow Medical® Transcatheter Aortic Valve System Continues To Demonstrate Excellent Outcomes at Six Months in Discover CE Mark Trial Results Featured in Oral Presentation at 25th Annual Transcatheter Cardiovascular Therapeutics (TCT) Conference SAN FRANCISCO,...
Advanced Cell Diagnostics Announces Genoptix® as their First CLIA Certified RNAscope® Service Provider Advanced Cell Diagnostic expands RNAscope® technology access through CLIA Service Provider Program HAYWARD, CA, November 5, 2013—Advanced Cell Diagnostics, Inc....
ReShape Medical® Successfully Meets Endpoints in Weight Loss Device Pivotal Trial ReShape Duo® is First to Achieve Important Milestone in the U.S. SAN CLEMENTE, CA, November 7, 2013 –ReShape Medical,® Inc. today announced that its REDUCE Trial for the ReShape Duo®...
Relypsa, Inc. Announces Pricing of Initial Public Offering REDWOOD CITY, Calif., Nov. 14, 2013 (GLOBE NEWSWIRE) — Relypsa, Inc. (Nasdaq:RLYP), a clinical-stage biopharmaceutical company, today announced the pricing of its initial public offering of 6,850,000...
Recent Comments